Liraglutide and Cardiometabolic Effects: More than Just Another Antiobesity Drug?

被引:14
|
作者
Katsiki, Niki [1 ]
Christou, Georgios A. [2 ]
Kiortsis, Dimitrios N. [2 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[2] Univ Ioannina, Sch Med, Lab Physiol, GR-45110 Ioannina, Greece
关键词
FATTY LIVER-DISEASE; LIPOPROTEIN LDL SUBCLASSES; CHRONIC KIDNEY-DISEASE; CLINICAL-SIGNIFICANCE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; HEART-RATE; DIABETES-MELLITUS; EUROPEAN PANEL; WEIGHT-LOSS;
D O I
10.2174/157016111401151126161741
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:76 / 79
页数:4
相关论文
共 50 条